C21 · Pharmaceuticals · United Kingdom
Pharmaceutical direct gross value added
United Kingdom: 20.4 billion GBP in as of 8 Sep 2026.
- 20.4 billion GBP Latest · United Kingdom · as of 8 Sep 2026
- Irregular Release cadence
- 1 Record · 1 region · 2026
Verified 17 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Pharmaceutical direct gross value added
United Kingdom, as of 8 Sep 2026
Every record
1 record · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| United Kingdom 1 record | |||
| as of 8 Sep 2026 | 20.4 billion GBP | ABPI · 8 Sep 2026 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: ABPI. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (ABPI); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Annual direct gross value added generated by the pharmaceutical industry.
- Measure
- One slice of Gross value added ( counting rule: direct, form: level ) . Total monetary value of goods and services produced less intermediate consumption. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Green shoots for UK pharma investment, but delivery will decide whether they take root | ABPI | — | 1 |
Other slices of gross value added
- ICT sector share of gross value added 7 ict sector
- ICT manufacturing share of gross value added 5 ict manufacturing
- ICT services share of gross value added 5 ict services
- Fitness facilities share of sports sector value added 3 fitness facilities
- Chemical raw materials and products manufacturing value added growth rate 2 constant currency · chemical raw materials and products
- ICT sector gross value added 2 ict
- Mobile industry contribution to GDP 2 mobile
- Value added growth rate, manufacture of foods 2 food manufacturing
- Value added growth rate, processing of food from agricultural and sideline products 2 agricultural sideline food processing
- Computer programming consultancy and related activities share of ICT services value added 1 computer programming consultancy and related activities
- Gross value added of sport sector 1 sport
- ICT manufacturing gross value added 1 ict manufacturing
Frequently asked questions
What is the latest pharmaceutical direct gross value added?
United Kingdom: 20.4 billion GBP in as of 8 Sep 2026.
Where does this data come from?
From 1 document published by ABPI. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical direct gross value added [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/pharmaceutical-direct-gross-value-added
"Pharmaceutical direct gross value added." StatOrigin, 2026, https://statorigin.org/indicators/pharmaceutical-direct-gross-value-added. Accessed 28 Oct. 2026.
StatOrigin. "Pharmaceutical direct gross value added." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/pharmaceutical-direct-gross-value-added.
@misc{statorigin_pharmaceutical_direct_gross_value_added_2026, title = {Pharmaceutical direct gross value added}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/pharmaceutical-direct-gross-value-added}, note = {Data set. Accessed 2026-10-28} }